Analysts expect that UnitedHealth Group Inc (NYSE:UNH) will report earnings per share (EPS) of $3.76 for the current fiscal quarter, Zacks Investment Research reports. Six analysts have made estimates for UnitedHealth Group’s earnings, with estimates ranging from $3.72 to $3.80. UnitedHealth Group reported earnings per share of $3.28 in the same quarter last year, which would suggest a positive year over year growth rate of 14.6%. The business is scheduled to announce its next quarterly earnings results on Tuesday, January 21st.
On average, analysts expect that UnitedHealth Group will report full year earnings of $14.97 per share for the current financial year, with EPS estimates ranging from $14.93 to $15.02. For the next fiscal year, analysts anticipate that the business will report earnings of $16.45 per share, with EPS estimates ranging from $16.36 to $16.52. Zacks’ earnings per share averages are an average based on a survey of analysts that follow UnitedHealth Group.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $3.88 earnings per share for the quarter, topping analysts’ consensus estimates of $3.75 by $0.13. UnitedHealth Group had a net margin of 5.57% and a return on equity of 25.30%. The company had revenue of $60.35 billion during the quarter, compared to analyst estimates of $59.84 billion. During the same period in the previous year, the business earned $3.41 EPS. The firm’s revenue for the quarter was up 6.7% on a year-over-year basis.
NYSE UNH traded up $1.98 during mid-day trading on Thursday, reaching $279.52. The stock had a trading volume of 2,378,835 shares, compared to its average volume of 4,443,206. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.70 and a quick ratio of 0.70. UnitedHealth Group has a 1 year low of $208.07 and a 1 year high of $283.04. The stock has a market cap of $265.46 billion, a PE ratio of 21.70, a price-to-earnings-growth ratio of 1.48 and a beta of 0.64. The company has a fifty day moving average price of $264.25 and a 200 day moving average price of $246.64.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be paid a dividend of $1.08 per share. This represents a $4.32 dividend on an annualized basis and a dividend yield of 1.55%. The ex-dividend date is Friday, December 6th. UnitedHealth Group’s dividend payout ratio (DPR) is 33.54%.
In other UnitedHealth Group news, Director Richard T. Burke sold 25,000 shares of the business’s stock in a transaction on Wednesday, October 16th. The shares were sold at an average price of $236.56, for a total value of $5,914,000.00. Following the sale, the director now owns 163,331 shares in the company, valued at approximately $38,637,581.36. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP D Ellen Wilson sold 7,400 shares of the business’s stock in a transaction on Monday, November 18th. The stock was sold at an average price of $272.77, for a total transaction of $2,018,498.00. In the last 90 days, insiders have sold 38,577 shares of company stock worth $9,398,080. 0.82% of the stock is owned by corporate insiders.
A number of hedge funds have recently made changes to their positions in the business. Eagle Capital Management LLC raised its position in shares of UnitedHealth Group by 0.9% during the 2nd quarter. Eagle Capital Management LLC now owns 16,213 shares of the healthcare conglomerate’s stock valued at $3,956,000 after buying an additional 147 shares in the last quarter. Texas Yale Capital Corp. bought a new position in UnitedHealth Group in the 2nd quarter worth about $383,000. Edge Capital Group LLC bought a new position in UnitedHealth Group in the 2nd quarter worth about $271,000. Wambolt & Associates LLC grew its stake in UnitedHealth Group by 14.9% in the 2nd quarter. Wambolt & Associates LLC now owns 1,523 shares of the healthcare conglomerate’s stock worth $372,000 after acquiring an additional 198 shares in the last quarter. Finally, KMG Fiduciary Partners LLC grew its stake in UnitedHealth Group by 17.8% in the 2nd quarter. KMG Fiduciary Partners LLC now owns 5,033 shares of the healthcare conglomerate’s stock worth $1,228,000 after acquiring an additional 760 shares in the last quarter. Institutional investors and hedge funds own 85.48% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.